Granules India arm wins USFDA approval for stimulant drug Amphetamine Sulfate tablets
Amphetamine Sulfate tablets is a generic version of Arbor Pharmaceuticals LLC's Evekeo tablets in similar strength, it added.
New Delhi: Drug firm Granules India on Tuesday said its US arm has received approval from the USFDA for a generic central nervous system stimulant drug, Amphetamine Sulfate tablets.
The US Food & Drug Administration (USFDA) has approved the abbreviated new drug application (ANDA) filed by the company's subsidiary, Granules Pharmaceuticals Inc, for Amphetamine Sulfate tablets USP 5 mg and 10 mg, Granules India said in a filing to BSE.
The product is a generic version of Arbor Pharmaceuticals LLC's Evekeo tablets in similar strength, it added.
"Amphetamine Sulfate tablets is a central nervous system stimulant used to treat a sleep disorder, increase attention, decrease impulsiveness and hyperactivity in patients with Attention Deficit Hyperactivity Disorder (ADHD)," Granules India said.
Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers. Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at firstname.lastname@example.org. Check out more about our bureau/team here